Humacyte, Inc. (HUMA) NASDAQ

2.54

-0.03(-1.17%)

Updated at July 09 04:00PM

Currency In USD

Valuation

Market Cap598.32M
Enterprise Value569.92M
P/E Ratio-4.29
PEG Ratio-0
Price/Sales Ratio50.77
Price/Book Ratio9.25
Enterprise/Revenue44.7
Enterprise/EBITDA-2.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-10.03
Operating Margin-14.33

Management Effectiveness

Return On Assets-0.48
Return On Equity2.86

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit0
EBITDA-132.23M
Net Income-148.7M
Diluted EPS-1.26

Balance Sheet

Total Cash62.85M
Total Cash/Share0.48
Total Debt15.85M
Total Debt/Equity0.44
Current Ratio3.68
Book Value Per Share0.27

Price History

52-Week Change-56.74
52-Week High9.79
52-Week Low1.15
Moving Average 50 Days2.12
Moving Average 200 Days3.61

Statistics

Average Volume4.11M
Shares Outstanding155.12M
% Held by Institutions46.26

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A